Getinge AB extends offer for US medical technology company Datascope Corp

Wed. October 29, 2008; Posted: 10:43 AM

Oct 29, 2008 (NORDIC BUSINESS REPORT via COMTEX) -- GNGBF | Quote | Chart | News | PowerRating -- Swedish medical technology company Getinge AB (OMX Stockholm:GETI B) said on Wednesday (29 October) that it has extended its offer for all shares of the US medical technology company Datascope Corp (NASDAQ:DSCP).

The offer, which is unchanged at USD53 per share in cash, is extended until 4 November.

Getinge initially announced its offer on 15 September and holds currently approximately 82.36% of the share capital of Datascope.

Datascope develops and manufactures products for counterpulsation therapy to improve blood circulation in coronary arteries, as well as products for vascular surgery and endovascular interventions. The company has some 765 employees and achieved sales of USD231m in the financial year 2007/2008.

Getinge's offer values the company at USD865m.

Getinge said earlier that the acquisition will strengthen its Cardiovascular division, its product portfolio and sales organisation, as well as result in significant synergies.

Getinge, headquartered in Getinge, Sweden, is a medical technical company active within surgery, intensive care, infection control and care ergonomics. The group has over 10,300 employees and reported sales of SEK16.4bn in 2007.

One British pound (GBP) is worth approximately 1.60 US dollars (USD). One British pound (GBP) is worth approximately 12.47 Swedish kronor (SEK).

Comments on this story may be sent to nbr.feedback@nordicbusinessreport.com

For full details for DSCP click here.

More News: Market Updates | Stock Alerts | All Trading News | Stock Index

Archives

Feedback

Email Article Link

Close X

RELATED SITES

Please call 1-213-955-5858 ext. 1

Tax Relief Bank Levy Wage Garnishment

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.